Home DailyMed c82e4407-7126-43fb-abc8-e217499e4c2b National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2013-02-13
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 03:22:29
Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN HYDROCODONE BITARTRATE; IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN HYDROCODONE BITARTRATE; IBUPROFEN 5MG;200MG TABLET / ORAL 2004-03-18 A076642-003 REPREXAIN HYDROCODONE BITARTRATE; IBUPROFEN 2.5MG;200MG TABLET / ORAL 2007-10-19 A076642-004 REPREXAIN HYDROCODONE BITARTRATE; IBUPROFEN 10MG;200MG TABLET / ORAL 2007-10-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A076642-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL 2004-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 84e616aacf4f…2026-08-18 06:07:40 2026-07 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL 2004-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL 2004-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL 2004-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL 2004-03-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL 2004-03-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL 2004-03-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL 2004-03-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL AB 2004-03-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076642-001 HYDROCODONE BITARTRATE AND IBUPROFEN 7.5MG;200MG TABLET / ORAL AB RS 2004-10-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076642-002 HYDROCODONE BITARTRATE AND IBUPROFEN 5MG;200MG TABLET / ORAL AB 2004-03-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076642-003 REPREXAIN 2.5MG;200MG TABLET / ORAL 2007-10-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076642-004 REPREXAIN 10MG;200MG TABLET / ORAL 2007-10-19 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 86 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.